The Burden of Diseases and Injury through The Lens of Standard Expected Years of Life Lost: The Lost Productivity and The Distribution of Health Attainment in Countries of Different Health Systems
DOI:
https://doi.org/10.54103/2282-0930/23489Keywords:
3P approach, lost earnings, lost life, person years lived, poverty alleviationAbstract
Background: The productivity loss attributable to the burden of diseases in different country contexts reflect the effectiveness of the context specific measures for population health development. So, this study provides insights into the productivity loss from the burden of diseases.
Methods: Using country specific subnational level data, we have quantified the burden of diseases and the consequential lost productivity in two lower middle-income countries i.e., India and Kyrgyzstan; three upper middle-income countries i.e., Belarus, Kazakhstan and the Russian Federation; and one high income country, France. We have computed standard expected years of life lost (SEYLL) as the measure of disease burden, and quantified the present value of lost earnings (PVLE) using our 3P approach (population, participation and productivity).
Results: Our subnational level analysis finds an overall declining trend of SEYLL across regions in each country except in Belarus from 2017 onwards, and in France. We also find that the cumulative percentage loss of PVLE per SEYLL mostly exceeds cumulative GDP per capita growth of the country during the study years.
Conclusion: We have captured the value of earnings and quantified the avoidable loss for the society/country in different contexts and thus, this study demonstrates the potential contribution of population health development to the poverty alleviation programme in low – and middle – income countries.
Downloads
References
1. Lucas Jr, RE. On the mechanics of economic development. J. Monet. Econ. 1988;22(1):3–42. DOI: https://doi.org/10.1016/0304-3932(88)90168-7
2. Romer PM. Increasing returns and long-run growth. J. Polit. Econ. 1986;94(5):1002–1037. DOI: https://doi.org/10.1086/261420
3. Well DN. Accounting for the effect of health on economic growth. Q. J. Econ. 2007;122(3):1265–1306. DOI: https://doi.org/10.1162/qjec.122.3.1265
4. Merette M. The bright side: a positive view on the economics of aging. Choices 2002;8:1–28.
5. Rivera B, Currais L. Economic growth and health: direct impact or reverse causation? Appl. Econ. Lett. 1999a;6(11):761–764. DOI: https://doi.org/10.1080/135048599352367
6. Rivera B, Currais L. Income variation and health expenditure: evidence for OECD countries. Rev. Dev. Econ. 1999b;3(3):258–267. DOI: https://doi.org/10.1111/1467-9361.00066
7. Knowles S, Owen PD. Health capital and cross-country variation in income per capita in the Mankiw-Romer-Weil model. Econ. Lett. 1995;48(1):99–106. DOI: https://doi.org/10.1016/0165-1765(94)00577-O
8. Knowles S, Owen PD. Education and health in an effective‐labour empirical growth model. Econ. Rec. 1997;73(223):314–328. DOI: https://doi.org/10.1111/j.1475-4932.1997.tb01005.x
9. Bloom DE, Canning DD, Sevilla J. The effects of health on economic growth: theory and evidence. Working Paper 8587. National Bureau of Economic Research, 2001.
10. World Health Organization. Macroeconomics and health: investing in health for economic development: report of the Commission on Macroeconomics and Health. In Macroeconomics and health: investing in health for economic development: report of the commission on macroeconomics and health 2001:202–202.
11. Field MJ, Gold MR. Summarizing population health—directions for the development and application of population metrics. Washington DC: National Academy Press, 1998.
12. Murray CJ, Mathers CD, Salomon JA, Lopez AD. Health gaps: an overview and critical appraisal. In Murray CJ, Editor. Summary measures of population health-concepts, ethics, measurement and applications. Geneva: World Health Organization, 2002:233–244.
13. Vlajinac H, Marinkovic J, Kocev N, Sipetic S, Bjegovic V, Jankovic S, Maksimovic J. Years of life lost due to premature death in Serbia (excluding Kosovo and Metohia). Public Health 2008;122(3):277–284. DOI: https://doi.org/10.1016/j.puhe.2007.06.010
14. Mariotti S, D’Errigo P, Mastroeni S, Freeman K. Years of life lost due to premature mortality in Italy. Eur. J. Epidemiol. 2003;18:513–521. DOI: https://doi.org/10.1023/A:1024635401206
15. Nahvijou A, Daroudi R, Javan-Noughabi J, Dehdarirad H, Faramarzi A. The lost productivity cost of premature mortality owing to cancers in Iran: evidence from the GLOBOCAN 2012 to 2018 estimates. Value Health Reg. Issues 2022;31:1–9. DOI: https://doi.org/10.1016/j.vhri.2022.02.002
16. Barchuk A, Bespalov A, Huhtala H, Chimed T, Belyaev A, Moore M, Soerjomataram I. Productivity losses associated with premature mortality due to cancer in Russia: A population-wide study covering 2001–2030. Scand. J. Public Health 2019;47(5):482–491. DOI: https://doi.org/10.1177/1403494819845565
17. Bencina G, Chami N, Hughes R, Weston G, Baxter C, Maciejczyk A, Salomonsson S. Breast cancer-related mortality in Central and Eastern Europe: years of life lost and productivity costs. J. of Med. Econ. 2023;26(1):254–261. DOI: https://doi.org/10.1080/13696998.2023.2169497
18. Abegunde D, Stanciole A. An estimation of the economic impact of chronic noncommunicable diseases in selected countries. World Health Organization, Department of Chronic Diseases and Health Promotion, 2006.
19. Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 2007;370(9603):1929–1938. DOI: https://doi.org/10.1016/S0140-6736(07)61696-1
20. Rumisha SF, George J, Bwana VM, Mboera LE. Years of potential life lost and productivity costs due to premature mortality from six priority diseases in Tanzania, 2006–2015. PLoS One 2020;15(6):e0234300.
21. Oliva-Moreno J, Peña-Longobardo LM, Alonso S, Fernández-Bolaños A, Gutiérrez ML, Hidalgo-Vega Á, et al. Labour productivity losses caused by premature death associated with hepatitis C in Spain. Eur J Gastroenterol Hepatol. 2015;27(6):631–637. DOI: https://doi.org/10.1097/MEG.0000000000000336
22. Kirigia JM, Muthuri RNDK, Nkanata LHK, et al. The discounted value of human lives lost due to COVID-19 in France. F1000Research. 2020; 9:1247. DOI: https://doi.org/10.12688/f1000research.26975.1
23. Rice DP, Hodgson TA, Kopstein AN. The economic costs of illness: a replication and update. HealthCare Financ Rev. 1985;7(1):61–80.
24. DeVol R, Bedroussian A, Charuworn A, Chatterjee A, Kim I, Kim S, et al. An unhealthy America: The economic burden of chronic disease. Santa Monica, CA: Milken Institute; 2007;326, 2010–2060.
25. Becker GS, Philipson TJ, Soares RR. The quantity and quality of life and the evolution of world inequality. Am Econ Rev. 2005;95(1):277–291. DOI: https://doi.org/10.1257/0002828053828563
26. Grossman M. (2000), The human capital model. In Michael Grossman, editor. Handbook of Health Economics, 2000: vol 1, Elsevier. DOI: https://doi.org/10.1016/S1574-0064(00)80166-3
27. Yabroff KR, Bradley CJ, Mariotto AB, Brown ML, Feuer EJ. Estimates and projections of value of life lost from cancer deaths in the United States. J Natl Cancer Inst. 2008;100(24):1755–1762. DOI: https://doi.org/10.1093/jnci/djn383
28. Rumisha SF, George J, Bwana VM, Mboera LE. Years of potential life lost and productivity costs due to premature mortality from six priority diseases in Tanzania, 2006–2015. PLoS ONE. 2020;15(6):e0234300. DOI: https://doi.org/10.1371/journal.pone.0234300
29. Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, et al. GBD 2010: design, definitions, and metrics. Lancet. 2012;380(9859):2063–2066. DOI: https://doi.org/10.1016/S0140-6736(12)61899-6
30. Murray CJ. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ. 1994;72(3):429.
31. Weisbrod BA. The valuation of human capital. J Polit Econ. 1961;69(5):425–436. DOI: https://doi.org/10.1086/258535
32. Fernandes NM, Silva JSGS, Varela DV, Lopes ED, Soares JDJX. The economic impact of premature mortality in Cabo Verde: 2016–2020. PLoS ONE. 2023;18(5):e0278590. DOI: https://doi.org/10.1371/journal.pone.0278590
33. Hanly P, Ahern M, Sharp L, Ursul D, Loughnane G. The cost of lost productivity due to premature mortality associated with COVID-19: a Pan-European study. Eur J Health Econ. 2022;23(2):249–259. DOI: https://doi.org/10.1007/s10198-021-01351-8
34. Menzin J, Marton JP, Menzin JA, Willke RJ, Woodward RM, Federico V. Lost productivity due to premature mortality in developed and emerging countries: an application to smoking cessation. BMC Med Res Methodol. 2012;12:87. DOI: https://doi.org/10.1186/1471-2288-12-87
35. Lange GM, Wodon Q, Carey K, editors. The changing wealth of nations 2018: Building a sustainable future. World Bank Publications 2018. DOI: https://doi.org/10.1596/978-1-4648-1046-6
36. Maniecka-Bryła I, Bryła M, Bryła P, Pikala M. The burden of premature mortality in Poland analysed with the use of standard expected years of life lost. BMC Public Health. 2015;15:1487. DOI: https://doi.org/10.1186/s12889-015-1487-x
37. Marshall RJ. Standard expected years of life lost as a measure of mortality: norms and reference to New Zealand data. Aust N Z J Public Health. 2004;28(5):452–457. DOI: https://doi.org/10.1111/j.1467-842X.2004.tb00944.x
38. Grosse SD, Krueger KV, Pike J. Estimated annual and lifetime labour productivity in the United States, 2016: implications for economic evaluations. J Med Econ. 2019;22(6):501–508. DOI: https://doi.org/10.1080/13696998.2018.1542520
39. Rizzuto D, Fratiglioni L. Lifestyle factors related to mortality and survival: a mini-review. Gerontology. 2014;60(4):327–335. DOI: https://doi.org/10.1159/000356771
40. Olejnik A, Zółtaszek A. The net effect of wealth on health—Investigating noncommunicable diseases mortality in the context of regional affluence. PLoS ONE. 2023;18(11):e0293887. DOI: https://doi.org/10.1371/journal.pone.0293887
41. Bloom DE, Canning DD, Sevilla J. The effects of health on economic growth: theory and evidence. Working Paper 8587. National Bureau of Economic Research; 2001. DOI: https://doi.org/10.3386/w8587
42. World Health Organization. Macroeconomics and health: investing in health for economic development: report of the Commission on Macroeconomics and Health. Geneva; 2001:202–202.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Eduardo Daniel López-Vila, Pavitra PAUL
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Accepted 2025-01-30
Published 2025-04-02
